Showing 3791-3800 of 21443 results for "".
- Mass General Brigham Study Highlights Varied Risk of Persistent COVID-19 Infection Among Immunocompromised Patientshttps://reachmd.com/news/mass-general-brigham-study-highlights-varied-risk-of-persistent-covid-19-infection-among-immunocompromised-patients/2456980/Patients who were severely immunocompromised were at greater risk of protracted disease and had a longer period in which they shed the virus, especially those with hematologic malignancy or transplant. While the sample size was limited, patients with mild/mode
- Researchers Pinpoint Most Likely Source of HIV Rebound Infectionhttps://reachmd.com/news/researchers-pinpoint-most-likely-source-of-hiv-rebound-infection/2456982/In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus to identify that lymph nodes in the abdomen are the leading source of
- Novel Approach Identifies People at Risk of Developing TBhttps://reachmd.com/news/novel-approach-identifies-people-at-risk-of-developing-tb/2456981/A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at increased risk of developing the disease that current methods of testing would not. Researchers at the National In
- UC Irvine-Led Study Links Biomarkers and Chemotherapy-Related Gastrointestinal Symptomshttps://reachmd.com/news/uc-irvine-led-study-links-biomarkers-and-chemotherapy-related-gastrointestinal-symptoms/2456973/Irvine, Calif., Jan. 24, 2024 — A study led by University of California, Irvine researchers has revealed a connection between blood levels of omega-3 and the inflammatory biomarker interleukin-8 and greater chemotherapy-related gastrointestinal symptoms in breast
- Scientists Discover New Genetic Cause of Inherited Kidney Diseasehttps://reachmd.com/news/scientists-discover-new-genetic-cause-of-inherited-kidney-disease/2456984/Genetic changes or mutations can cause hereditary kidney disease, which can eventually lead to dialysis or the need for kidney transplantation. Identifying the cause of inherited kidney disease is the first step in identifying a treatment.
- Study Evaluates Outcomes of Catheter-Based Therapy for Patients with Cancer and Intermediate- or High-Risk Pulmonary Embolismhttps://reachmd.com/news/study-evaluates-outcomes-of-catheter-based-therapy-for-patients-with-cancer-and-intermediate-or-high-risk-pulmonary-embolism/2456971/January 11, 2024—A study published online in Catheterization and Cardiovascular Interventions by Leiva et al evaluating outcomes of patients with cancer hospitalized with in
- The Influence of Microbiologists in Spain During COVID-19 Helped Public Hospital Laboratories to Be More Prepared Today Than Before the Pandemichttps://reachmd.com/news/the-influence-of-microbiologists-in-spain-during-covid-19-helped-public-hospital-laboratories-to-be-more-prepared-today-than-before-the-pandemic/2456978/Researchers from INGENIO, a joint center of the Consejo Superior de Investigaciones CientÃficas (CSIC) and the Universitat PolitÚcnica de ValÚncia (UPV), have recently published, together with two co-authors from the University of Sussex (UK), the results of a study on t
- Study: UAB Researchers Establish Optimal Immunosuppression Regimen for Pig-to-Human Kidney Transplantshttps://reachmd.com/news/study-uab-researchers-establish-optimal-immunosuppression-regimen-for-pig-to-human-kidney-transplants/2456983/Currently used Food and Drug Administration-approved transplant drugs — with the addition of an also already FDA-approved complement inhibitor — are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by
- ARCADIA 1 and 2: Nemolizumab Reduces Itch, Sleep Disturbance in Atopic Dermatitishttps://reachmd.com/news/arcadia-nemolizumab-reduces-itch-sleep-disturbance-in-atopic-dermatitis/2462226/Nemolizumab, an interleukin-31 (IL-31) receptor alpha antagonist, demonstrated significant efficacy in adults and adolescents with atopic dermatitis (AD) in a pair of identical trials, according to new study results pre
- Interim Analysis: Tralokinumab Improves Quality of Life in Moderate-to-Severe Atopic Dermatitishttps://reachmd.com/news/interim-analysis-tralokinumab-improves-quality-of-life-in-moderate-to-severe-atopic-dermatitis/2462224/Tralokinumab, an interleukin-13 (IL-13) inhibitor approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults, was shown to improve several quality of life measures, a 6-month interim analysis sugg